RKDA logo

Arcadia Biosciences (RKDA)

Profile

Full Name

Arcadia Biosciences, Inc.

Ticker Symbol

RKDA

Exchange

NASDAQ

Sector

Consumer Defensive

Industry

Packaged Foods

Country

United States

IPO

May 15, 2015

Indexes

Not included

Website

http://www.arcadiabio.com

Employees

9

Key Details

Price

$2.95(-6.64%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$5.04M(+13.27% YoY)

Annual EPS

-$5.17(+54.21% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.95
RKDA price is $2.95

30-Day Relative Volume

0.45
RKDA 30-day relative volume is 0.45

Price Performance

Price Most recent change

-6.64%
RKDA price was down -6.64% on Apr 17, 2025

Price YTD change

-50.1%
RKDA price is down -50.1% since January 1st

Price 1-year change

+45.52%
RKDA price is up +45.52% year-on-year

Price 3-year change

-93.1%
RKDA price is down -93.1% over the past 3 years

Price Range

Price All-time high

$7040.00
RKDA price is currently -99.96% below its historical high of $7040.00

Price 3-year low

$1.85
RKDA price is currently +59.59% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$4.03M
RKDA market capitalization is $4.03 million

Market cap 3-year change

-83.02%
RKDA market capitalization is down -83.02% over the past 3 years

Market cap All-time high

$377.14M
RKDA market capitalization is currently -98.93% below its historical high of $377.14 million

Market cap sector rank

8%
RKDA market capitalization is higher than 8% of companies in Consumer Defensive sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.15%
RKDA shares outstanding is up +0.15% year-on-year

Shares Outstanding 3-Year Change

+146.06%
RKDA shares outstanding is up +146.06% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.74
RKDA beta is 0.74

200-day SMA

$3.71
RKDA price is currently -20.33% below its 200-day simple moving average

50-day SMA

$3.57
RKDA price is currently -17.17% below its 50-day simple moving average

RSI

43.62
RKDA 14-day relative strength index is 43.62

Volume

0.45
RKDA 30-day relative volume is 0.45

ATR

$0.28
RKDA average true range is $0.28

10-day Historical Volatility

83.20%
RKDA 10-day historical volatility is 83.20%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$5.04M
RKDA annual revenue is $5.04 million

Revenue Analysts estimate

$6.50M
RKDA annual revenue is currently -22.38% lower than the consensus analysts' forecast

Revenue 1-year change

+13.27%
RKDA annual revenue is up +13.27% year-on-year

Revenue Sector rank

6.37%
RKDA annual revenue is higher than 6.37% of companies in Consumer Defensive sector

EPS

EPS

-$5.17
RKDA annual earnings per share is -$5.17

EPS Analysts estimate

-
RKDA annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+54.21%
RKDA annual earnings per share is up +54.21% year-on-year

EPS Sector rank

10.53%
RKDA annual earnings per share is higher than 10.53% of companies in Consumer Defensive sector

Profit

Gross profit

$2.08M
RKDA annual gross profit is $2.08 million

Gross margin

41.27%
RKDA annual gross profit margin is 41.27%

Operating profit

-$7.61M
RKDA annual operating income is -$7.61 million

Operating margin

-150.88%
RKDA annual operating profit margin is -150.88%

Net income

-$7.04M
RKDA annual net profit is -$7.04 million

Net margin

-139.50%
RKDA annual net profit margin is -139.50%

Expenses

Total expenses

$12.66M
RKDA annual total expenses is $12.66 million

Operating expenses

$9.69M
RKDA annual total operating expenses is $9.69 million

Cost of goods sold

$2.96M
RKDA annual cost of goods sold is $2.96 million

Selling, general & administrative expenses

$9.64M
RKDA annual SGA is $9.64 million

Depreciation and amortization

$765.00K
RKDA annual depreciation & amortization is $765.00 thousand

Interest expense

-
RKDA annual interest expense value is unknown

Income tax

$8000.00
RKDA annual income tax is $8000.00

EBIT & EBITDA

EBIT

-$7.61M
RKDA annual earnings before interest & taxes is -$7.61 million

EBITDA

-$6.85M
RKDA annual EBITDA is -$6.85 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$13.52M
RKDA annual total assets is $13.52 million

Non current assets

$4.28M
RKDA annual long term assets is $4.28 million

Current assets

$9.24M
RKDA annual total current assets is $9.24 million

Cash and cash equivalents

$4.24M
RKDA annual cash & cash equivalents is $4.24 million

Accounts receivable

$1.18M
RKDA annual accounts receivable is $1.18 million

Inventory

$904.00K
RKDA annual inventory is $904.00 thousand

Liabilities

Total liabilities

$7.29M
RKDA annual total liabilities is $7.29 million

Long term liabilities

$4.73M
RKDA annual total long term liabilities is $4.73 million

Current liabilities

$2.56M
RKDA annual total current liabilities is $2.56 million

Accounts payable

$2.11M
RKDA annual accounts payable is $2.11 million

Debt

Total debt

$155.00K
RKDA annual total debt is $155.00 thousand

Total debt 1-year change

-84.61%
RKDA annual total debt is down -84.61% year-on-year

Long term debt

$0.00
RKDA annual long term debt is $0.00

Short term debt

$155.00K
RKDA annual short term debt is $155.00 thousand

Equity & Capital

Shareholders equity

$6.22M
RKDA annual stockholders equity is $6.22 million

Book value

$6.22M
RKDA annual book value is $6.22 million

Retained earnings

-$278.88M
RKDA annual retained earnings is -$278.88 million

Working capital

$6.68M
RKDA annual working capital is $6.68 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$9.63M
RKDA annual cash flow from operations is -$9.63 million

Cash from operations 1-year change

+37.05%
RKDA annual cash flow from operations is up +37.05% year-on-year

Cash from investing

$7.34M
RKDA annual cash flow from investing activities is $7.34 million

Cash from investing 1-year change

+269.01%
RKDA annual cash flow from investing activities is up +269.01% year-on-year

Cash from financing

$9000.00
RKDA annual cash flow from financing activities is $9000.00

Cash from financing 1-year change

-99.84%
RKDA annual cash flow from financing activities is down -99.84% year-on-year

CAPEX

CAPEX

$16.00K
RKDA annual capital expenditures is $16.00 thousand

CAPEX 1-year change

+220%
RKDA annual capital expenditures is up +220% year-on-year

Free Cash Flow

Free cash flow

-$9.64M
RKDA annual free cash flow is -$9.64 million

Free cash flow 1-year change

+36.97%
RKDA annual free cash flow is up +36.97% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

41.27%
RKDA annual gross profit margin is 41.27%

Operating margin

-150.88%
RKDA annual operating profit margin is -150.88%

Net margin

-139.50%
RKDA annual net profit margin is -139.50%

ROA & ROE

ROA

-42.37%
RKDA annual return on assets is -42.37%

ROE

-74.37%
RKDA annual return on equity is -74.37%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
RKDA price to earnings ratio value is unknown

PE ratio Sector rank

-
RKDA price to earnings ratio is unknown

PB Ratio

PB ratio

0.65
RKDA price to book ratio is 0.65

PB ratio Sector rank

25.51%
RKDA price to book ratio is higher than 25.51% of companies in Consumer Defensive sector

PS Ratio

PS ratio

0.76
RKDA price to sales ratio is 0.76

PS ratio Sector rank

43.58%
RKDA price to sales ratio is higher than 43.58% of companies in Consumer Defensive sector

Enterprise value

Enterprise value

-$55.09K
RKDA enterprise value is -$55.09 thousand

Enterprise value Sector rank

2.83%
RKDA enterprise value is higher than 2.83% of companies in Consumer Defensive sector

EV/EBITDA

EV/EBITDA

0.01
RKDA EV/EBITDA is 0.01

EV/EBITDA Sector rank

27.06%
RKDA EV/EBITDA is higher than 27.06% of companies in Consumer Defensive sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.61
RKDA annual current ratio is 3.61

Quick ratio

3.25
RKDA annual quick ratio is 3.25

Leverage

Debt to equity

0.00
RKDA annual debt to equity ratio is 0.00

Interest coverage ratio

-
RKDA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

3
RKDA piotroski f-score is 3

Altman Z-Score

-29.44
RKDA altman z-score is -29.44

Analyst ratings

Recent major analysts updates

Aug 21, 24 HC Wainwright & Co.
Buy
May 23, 24 HC Wainwright & Co.
Buy
Apr 5, 24 HC Wainwright & Co.
Buy
Aug 28, 23 HC Wainwright & Co.
Buy
Jul 24, 23 HC Wainwright & Co.
Buy
Jun 5, 23 HC Wainwright & Co.
Buy
Apr 14, 23 HC Wainwright & Co.
Buy
Aug 26, 22 HC Wainwright & Co.
Buy
Jan 3, 22 HC Wainwright & Co.
Buy
Jun 1, 21 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

BTTR logo
Better Choice (BTTR)
Healthy Choice Wellness (HCWC)
ASPU logo
Aspen (ASPU)
Longevity Health Holdings (XAGE)
Valeo SE - ADR (VSA)
TCTM logo
TCTM Kids IT Education (TCTM)
CTCX logo
Carmell Therapeutics (CTCX)
Heritage Distilling Holding (CASK)
LQR House (YHC)
  • What is the ticker symbol for Arcadia Biosciences?
  • Does Arcadia Biosciences pay dividends?
  • What sector is Arcadia Biosciences in?
  • What industry is Arcadia Biosciences in?
  • What country is Arcadia Biosciences based in?
  • When did Arcadia Biosciences go public?
  • Is Arcadia Biosciences in the S&P 500?
  • Is Arcadia Biosciences in the NASDAQ 100?
  • Is Arcadia Biosciences in the Dow Jones?
  • When was Arcadia Biosciences's last earnings report?
  • When does Arcadia Biosciences report earnings?
  • Should I buy Arcadia Biosciences stock now?

What is the ticker symbol for Arcadia Biosciences?

The ticker symbol for Arcadia Biosciences is NASDAQ:RKDA

Does Arcadia Biosciences pay dividends?

No, Arcadia Biosciences does not pay dividends

What sector is Arcadia Biosciences in?

Arcadia Biosciences is in the Consumer Defensive sector

What industry is Arcadia Biosciences in?

Arcadia Biosciences is in the Packaged Foods industry

What country is Arcadia Biosciences based in?

Arcadia Biosciences is headquartered in United States

When did Arcadia Biosciences go public?

Arcadia Biosciences's initial public offering (IPO) was on May 15, 2015

Is Arcadia Biosciences in the S&P 500?

No, Arcadia Biosciences is not included in the S&P 500 index

Is Arcadia Biosciences in the NASDAQ 100?

No, Arcadia Biosciences is not included in the NASDAQ 100 index

Is Arcadia Biosciences in the Dow Jones?

No, Arcadia Biosciences is not included in the Dow Jones index

When was Arcadia Biosciences's last earnings report?

Arcadia Biosciences's most recent earnings report was on Mar 20, 2025

When does Arcadia Biosciences report earnings?

The next expected earnings date for Arcadia Biosciences is May 9, 2025

Should I buy Arcadia Biosciences stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page